Defining avoidable healthcare-associated harm in prisons: A mixed-method development study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 05 07 2022
accepted: 06 02 2023
entrez: 15 3 2023
pubmed: 16 3 2023
medline: 21 3 2023
Statut: epublish

Résumé

Reducing avoidable healthcare-associated harm is a global health priority. Progress in evaluating the burden and aetiology of avoidable harm in prisons is limited compared with other healthcare sectors. To address this gap, this study aimed to develop a definition of avoidable harm to facilitate future epidemiological studies in prisons. Using a sequential mixed methods study design we first characterised and reached consensus on the types and avoidability of patient harm in prison healthcare involving analysis of 151 serious prison incidents reported to the Strategic Executive Information System (StEIS) followed by in-depth nominal group (NG) discussions with four former service users and four prison professionals. Findings of the NG discussions and StEIS analysis were then synthesised and discussed among the research team and study oversight groups to develop an operational definition of avoidable harm in prison healthcare which was subsequently tested and validated using prison patient safety incident report data derived from the National Reporting and Learning System (NRLS). Analysis of StEIS incident reports and NG discussions identified important factors influencing avoidable harm which reflected the unique prison setting, including health care delivery issues and constraints associated with the secure environment which limited access to care. These findings informed the development of a new working two-tier definition of avoidable harm using appropriate and timely intervention, which included an additional assessment of harm avoidability taking into the account the prison regime and environment. The definition was compatible with the NRLS incident report narratives and illustrated how the prison environment may influence identification of avoidable harm and judgements of avoidability. We have developed a working definition of avoidable harm in prison health care that enables consideration of caveats associated with prison environments and systems. Our definition enables future studies of the safety of prison healthcare to standardise outcome measurement.

Sections du résumé

BACKGROUND
Reducing avoidable healthcare-associated harm is a global health priority. Progress in evaluating the burden and aetiology of avoidable harm in prisons is limited compared with other healthcare sectors. To address this gap, this study aimed to develop a definition of avoidable harm to facilitate future epidemiological studies in prisons.
METHODS
Using a sequential mixed methods study design we first characterised and reached consensus on the types and avoidability of patient harm in prison healthcare involving analysis of 151 serious prison incidents reported to the Strategic Executive Information System (StEIS) followed by in-depth nominal group (NG) discussions with four former service users and four prison professionals. Findings of the NG discussions and StEIS analysis were then synthesised and discussed among the research team and study oversight groups to develop an operational definition of avoidable harm in prison healthcare which was subsequently tested and validated using prison patient safety incident report data derived from the National Reporting and Learning System (NRLS).
RESULTS
Analysis of StEIS incident reports and NG discussions identified important factors influencing avoidable harm which reflected the unique prison setting, including health care delivery issues and constraints associated with the secure environment which limited access to care. These findings informed the development of a new working two-tier definition of avoidable harm using appropriate and timely intervention, which included an additional assessment of harm avoidability taking into the account the prison regime and environment. The definition was compatible with the NRLS incident report narratives and illustrated how the prison environment may influence identification of avoidable harm and judgements of avoidability.
CONCLUSIONS
We have developed a working definition of avoidable harm in prison health care that enables consideration of caveats associated with prison environments and systems. Our definition enables future studies of the safety of prison healthcare to standardise outcome measurement.

Identifiants

pubmed: 36920916
doi: 10.1371/journal.pone.0282021
pii: PONE-D-22-19014
pmc: PMC10016636
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0282021

Subventions

Organisme : Department of Health
ID : PR-R20-0318-21001
Pays : United Kingdom

Informations de copyright

Copyright: © 2023 Keers et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMJ. 2000 Mar 18;320(7237):726-7
pubmed: 10720336
Acad Med. 2017 Oct;92(10):1491-1498
pubmed: 28678098
J Clin Nurs. 2007 Jul;16(7):1201-9
pubmed: 17584337
Qual Saf Health Care. 2008 Feb;17(1):53-7
pubmed: 18245220
BMJ Qual Saf. 2014 Aug;23(8):670-7
pubmed: 24764136
Br J Gen Pract. 2015 Dec;65(641):e829-37
pubmed: 26622036
BMC Fam Pract. 2018 Jul 18;19(1):117
pubmed: 30021508
BMJ Qual Saf. 2012 Sep;21(9):737-45
pubmed: 22927487
BMJ. 2019 Jul 17;366:l4185
pubmed: 31315828
J Innov Health Inform. 2018 Oct 31;25(3):196-198
pubmed: 30398464
J Patient Saf. 2021 Aug 1;17(5):341-351
pubmed: 34276036
Int J Clin Pharm. 2016 Jun;38(3):655-62
pubmed: 26846316
Br J Psychiatry. 2019 May 9;:1-3
pubmed: 31068228
BMJ. 2003 Apr 12;326(7393):816-9
pubmed: 12689983
Milbank Q. 2005;83(4):691-729
pubmed: 16279964
BMJ. 2023 Jan 4;380:o3068
pubmed: 36599468
PLoS Med. 2017 Jan 17;14(1):e1002217
pubmed: 28095408
BMJ Support Palliat Care. 2019 Aug 28;:
pubmed: 31462421
Pediatrics. 2015 Jun;135(6):1027-35
pubmed: 25941305
BMJ Qual Saf. 2016 Jul;25(7):544-53
pubmed: 26715764
Am J Public Health. 1972 Mar;62(3):337-42
pubmed: 5011164
Br Med Bull. 2018 Mar 1;125(1):15-23
pubmed: 29394343
Soc Sci Med. 2000 Dec;51(11):1611-25
pubmed: 11072882
Br J Gen Pract. 2003 Oct;53(495):798-800
pubmed: 14601357
BMJ. 2022 Dec 19;379:o3019
pubmed: 36535705
BMC Med. 2020 Nov 6;18(1):313
pubmed: 33153451
Br J Gen Pract. 2014 Apr;64(621):e181-90
pubmed: 24686882
BMC Fam Pract. 2014 Jun 05;15:110
pubmed: 24902490
Age Ageing. 2017 Sep 1;46(5):833-839
pubmed: 28520904
Addiction. 2020 Nov;115(11):2066-2076
pubmed: 32149443
PLoS One. 2022 Nov 3;17(11):e0275907
pubmed: 36327312
Br Dent J. 2000 Mar 11;188(5):237-40
pubmed: 10758684
Int J Nurs Stud. 2004 Feb;41(2):119-28
pubmed: 14725776
Crim Behav Ment Health. 2020 Jun;30(2-3):59-64
pubmed: 32495973
J R Soc Med. 2018 Feb;111(2):57-64
pubmed: 29169009
Paediatr Drugs. 2021 May;23(3):287-297
pubmed: 33830469
J Epidemiol Community Health. 2001 May;55(5):364-5
pubmed: 11297662
BMJ Qual Saf. 2021 Dec;30(12):961-976
pubmed: 33172907
Front Psychiatry. 2020 Apr 21;11:328
pubmed: 32372990
BMC Fam Pract. 2019 Oct 4;20(1):134
pubmed: 31585529

Auteurs

Richard N Keers (RN)

Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, University of Manchester, Manchester, United Kingdom.
NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Science Network, Manchester, United Kingdom.
Suicide, Risk and Safety Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, United Kingdom.

Verity Wainwright (V)

Centre for Mental Health and Safety, Division of Psychology and Mental Health, University of Manchester, Manchester, United Kingdom.

Joy McFadzean (J)

Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Kate Davies (K)

Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Stephen M Campbell (SM)

NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Science Network, Manchester, United Kingdom.
Epidemiology and Public Health Group, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, United Kingdom.
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Caroline Stevenson (C)

Centre for Mental Health and Safety, Division of Psychology and Mental Health, University of Manchester, Manchester, United Kingdom.

Thomas Purchase (T)

Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Jennifer Shaw (J)

Suicide, Risk and Safety Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, United Kingdom.
Centre for Mental Health and Safety, Division of Psychology and Mental Health, University of Manchester, Manchester, United Kingdom.
Independent Advisory Panel on Deaths in Custody, United Kingdom.

Andrew Carson-Stevens (A)

Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH